In a sup­ply chain short­age workaround, Aus­trali­a's Vic­to­ria state aims to build its own mR­NA fa­cil­i­ty

As coun­tries all around the world have ex­pe­ri­enced trou­bles with vac­cine short­ages, Aus­tralia’s Vic­to­ria state is de­vel­op­ing its own mR­NA man­u­fac­tur­ing fa­cil­i­ty in an ef­fort to up its num­ber of vac­ci­nat­ed res­i­dents.

Vic­to­ria will spend $39 mil­lion to set up the fa­cil­i­ty, which could be the first in the south­ern hemi­sphere, Reuters re­port­ed. The mR­NA tech­nol­o­gy is used in the Pfiz­er-BioN­Tech and Mod­er­na vac­cines, and has got­ten more at­ten­tion, as ade­n­ovirus-based vac­cines from As­traZeneca and J&J have had re­ports of rare, but sim­i­lar blood clots in some pa­tients. There have been no re­ports of ma­jor side ef­fects in ei­ther Mod­er­na or Pfiz­er’s jab.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.